PNV 1.30% $2.33 polynovo limited

The Clinicians Speak, page-4

  1. 280 Posts.
    lightbulb Created with Sketch. 170
    Thanks for the work you have put into that compilation. It will be a valuable resource.

    I don't know if there are any on that list that I haven't read over the past two or three years but what I can say is that all the many reports and case studies that I have read have been highly positive. Every single one, at least as far as I can recall. This is why I remain confident that Polynovo will achieve dominance in the near term in the dermal scaffold market and is very likely to succeed in other areas, too. But I am eager, of course, to read any negative clinical commentary thst anyone is aware of. Can anyone point me to any? Is there anything critical in that list?
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.33
Change
0.030(1.30%)
Mkt cap ! $1.609B
Open High Low Value Volume
$2.29 $2.34 $2.27 $2.949M 1.276M

Buyers (Bids)

No. Vol. Price($)
5 19139 $2.31
 

Sellers (Offers)

Price($) Vol. No.
$2.34 14111 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.